Woburn, MA – YASH Technologies, a global enterprise solutions provider, announced today that Microbia, Inc., an emerging industrial biotechnology company, has selected ChemOne as its integrated Enterprise Resource Planning (ERP) solution. ChemOne will provide the foundation for operational efficiency for Microbia’s manufacturing and business requirements to prepare them for the launch of their line of naturally derived carotenoids for the food ingredient and nutritional supplement markets.
ChemOne is a certified SAP® Business All-in-One solution that is specifically designed for Small to Medium Enterprises (SMEs) in the chemical industry. It accelerates an organization’
“YASH is excited to partner with Microbia on their ERP initiative,”
Microbia is positioning itself as a future market leader in the production of sustainable, specialty ingredients and biomaterials utilizing fermentation technology. The comprehensive functionality of ChemOne supports the key business processes of planning, procurement, sales, and analysis in a single platform, and it incorporates industry best practices for standard operating processes required by chemical and biotechnology companies.
“Microbia decided to invest in an SAP solution that would provide the necessary level of integration to support our commitment to innovation, leadership and growth in the biotechnology industry,” said Rich Bailey, President and CEO of Microbia. “In addition, Microbia specified key manufacturing capabilities to ensure compliance with product traceability and safety requirements – critical considerations in today’s marketplace.”
About MICROBIA
Microbia is an industrial biotechnology company applying proprietary metabolic engineering to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and commercialize its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia’s carotenoids will be the first products launched from a diverse pipeline of specialty ingredients, biopolymers and other biomaterials. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.
